Macromastia Clinical Trial
Official title:
Multi-centre Study to Show Equivalence of Prineo (DERMABOND PROTAPE) to Intradermal Sutures for Skin Closure of Full-thickness Surgical Incisions Associated With Breast Procedures
This is a prospective, controlled, randomized, multi-center clinical study of up to 80 patients with full thickness surgical incisions associated with bi-lateral breast procedures. Breast procedures where symmetrical incisions of at least 15cm in length are planned for both breast (bilateral procedure) will be randomised to receive final skin closure of one breast with Prineo (DERMABOND PROTAPE) and the other with intradermal sutures (control). Patients will be evaluated post-operatively at 24 hours (± 6 hours), 7 days (± 1 day), 12 - 25 days, and 90 days (± 10 days).
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05288530 -
Satisfaction, Pain and Function Outcomes of Breast Reduction Patients
|
||
Terminated |
NCT01284491 -
A Study to Evaluate Cutaneous Scar Quality Following Bilateral Breast Reduction With the PEAK PlasmaBlade 4.0
|
N/A | |
Completed |
NCT00986453 -
PEAK PlasmaBlade 4.0 in Bilateral Breast Reduction
|
N/A | |
Completed |
NCT02769559 -
Reduction Mammaplasty and Improved Quality of Life
|
N/A | |
Terminated |
NCT02016677 -
An Observational Study Exploring the Esthetic Outcomes of Breast Reduction Surgery and /or Mastopexy
|
N/A | |
Recruiting |
NCT05898087 -
Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty
|
Phase 4 |